.png)
Confirm the Meningioma. Then Build the Case.
Surface medroxyprogesterone dispensing history, meningioma diagnoses, and neurosurgical treatment across your Depo-Provera docket
Depo-Provera litigation is one of the fastest-growing mass torts in 2026. Over 3,000 cases are now pending in MDL 3140, alleging that long-term use ofthe injectable contraceptive caused meningioma brain tumors. The FDA added a meningioma warning to the Depo-Provera label in December 2025, and new studies show women with prolonged use face more than double the risk of developing these tumors.
Each claim requires documented proof of Depo-Provera use and a confirmed meningioma diagnosis. At intake, claimants know they used the birth control shot and developed a brain tumor, but reconstructing the complete injection history and treatment timeline across providers is challenging.
SettLiT provides the digital health intelligence layer that helps firms qualify Depo-Provera claimants earlier, verify injection history through pharmacy benefit data, and surface the neurosurgical treatment picture before record retrieval begins.
What Makes Depo-Provera Qualifcation Operationally Demanding
Depo-Provera litigation requires firms to establish both the injection history and the brain tumor diagnosis. Claimants received injections every three months, often for years or decades, across multiple providers. The medical record connecting to meningioma diagnosis is rarely complete at intake.
inCOMPLETE INTAKE NARRATIVES
Claimants who used Depo-Provera for years rarely remember every provider. SettLiT finds the clinics your client forgot: primary care offices, OB-GYN practices, Planned Parenthood locations, urgent care, campus health centers.
SLOW MEDICAL RECORD RETRIEVAL
Without knowing every provider who administered injections, firms cannot document the full use history. Identifying the right facilities takes weeks before retrieval can begin.
CAPITAL DEPLOYED TOO EARLY
Firms invest in case workup before confirming the injection timeline and meningioma diagnosis meet qualification criteria. Cases that fall short of the one-year use threshold still absorb the cost of that commitment.
LATE LITIGATION
SURPRISES
Defense uncovers gaps in the injection history, alternative tumor explanations, or prior neurological conditions that plaintiff counsel was never aware of. The growing focus on preemption defenses makes complete documentation even more critical.
Verify the Injection History Before You Build the Case
The firms building stronger Depo-Provera dockets are not starting with retrieval. They are starting with intelligence, structured health data that confirms the injection timeline and meningioma diagnosis support the case before resources are committed.
What SettLiT Surfaces in Depo-Provera Cases
SettLiT connects to national health data networks and structured medical datasets to surface the signals that matter in Depo-Provera litigation.
These may include:
Medroxy-progesterone (Depo-Provera) dispensing records with NDC codes and date
Meningioma diagnoses and brain tumor diagnosis codes
Treating providers across neurology, neurosurgery, and imaging centers
Neurosurgical procedures including craniotomy and tumor resection
Treatment timelines that establish the arc from first injection to diagnosis
Mapping Data to Depo-Provera Eligibility
Depo-Provera claims require documented injection history and brain tumor diagnosis. SettLiT maps directly to the evidentiary requirements:
Medroxy-progesterone Dispensing History
Pharmacy benefit data returns Depo-Provera and medroxyprogesterone dispensing records with NDC codes and dates of administration
Meningioma Diagnosis
Claims data returns intracranial meningioma diagnoses with date of first diagnosis and tumor location when available
Neurosurgical Treatment History
Treatment data shows craniotomy, tumor resection, radiation treatment, and ongoing monitoring procedures
3,000+ Cases and Growing. Each One Unique.
Depo-Provera dockets are growing rapidly, with over 1,000 new cases filed in a single month. But the strength of each case still depends on one claimant's specific injection history, one meningioma diagnosis, one treatment timeline that either supports the claim or introduces complications.
SettLiT surfaces that individual picture at scale, structured health intelligence across every claimant in your docket so qualification decisions are grounded in verified data rather than what claimants remember from intake.
Confirm the Timeline Before You Commit
Depo-Provera qualification hinges on proving sustained use, typically two or more injections over at least a year. Claimants rarely remember every provider who administered a shot over a decade of use. Without that injection timeline, firms commit resources to cases that may fall short of the threshold.
SettLiT surfaces medroxyprogesterone dispensing records from pharmacy benefit data before retrieval begins. Know whether the injection history meets qualification criteria before you invest in case workup.
Find It Before Pfizer Does
Pfizer is actively pursuing preemption defenses in the Depo-Provera MDL, arguing that the FDA prevented the company from adding a meningioma warning. Defense teams will scrutinize injection history completeness, look for gaps in use, and identify alternative explanations for the tumor. The question is whether you find these issues first.
SettLiT gives your team the same visibility into the claimant's medical history that defense will eventually obtain. Identify complicating factors early. Adjust strategy before you commit resources. Build cases that survive scrutiny from day one.
Why Firms Choose SettLit For Depo-Provera Qualification
digital health intelligence First
Surface medroxyprogesterone dispensing records and meningioma diagnoses before retrieval begins.
Provider discovery
Identify OB-GYNs, primary care providers, clinics, neurologists, and neurosurgeons across the claimant's care history.
structured medical outputs
Receive NDC-coded injection records, diagnosis codes, and treatment timelines in formats built for Depo-Provera litigation workflows.
Targeted retrieval enablement
Focus retrieval on the neurosurgical facilities and imaging centers most likely to produce records that advance the case.
Scalable docket workflows
Process thousands of Depo-Provera claimants with the same rigor you would apply to one.
Integration Ready Infrastructure
API and portal access. Integrates with Filevine and Smart Advocate.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
